Amobarbital
Back to searchMolecule Structure
Scientific Name
Amobarbital
Description of the Drug
Amobarbital is a barbiturate derivative used for the induction of sedation during procedures, short-term management of insomnia, and acute management of refractory tonic-clonic seizures.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01351
http://www.drugbank.ca/drugs/DB01351
Brand Name(s)
Amytal
Company Owner(s)
Not Available
Mechanism(s) Of Action
Not Available
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL43780 | ||
| PharmGKB | PA448401 | ||
| Human Metabolome Database | HMDB0015440 | ||
| DrugBank | DB01351 | ||
| PubChem: Thomson Pharma | 15415185 | ||
| PubChem | 2164 | ||
| NMRShiftDB | 20200623 | ||
| Nikkaji | J1.381A | ||
| EPA CompTox Dashboard | DTXSID9020081 | ||
| DrugCentral | 184 | ||
| Brenda | 43764 | 3064 | |
| rxnorm | AMOBARBITAL SODIUM | AMOBARBITAL | AMYTAL |
| KEGG Ligand | C07536 | ||
| ChEBI | 2673 | ||
| ZINC | ZINC000004811698 |
